|
Summary Information: Intercept Pharmaceuticals Inc. Common Stock NASDAQ:ICPT |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.
__The following are links to various summary and news pages for __Intercept Pharmaceuticals Inc. Common Stock [ ICPT ]. __Note: Some Links might not have information for the company. |
|